Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validity of The Health Improvement Network (THIN) for the study of psoriasis.
Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM. Seminara NM, et al. Among authors: gelfand jm. Br J Dermatol. 2011 Mar;164(3):602-9. doi: 10.1111/j.1365-2133.2010.10134.x. Epub 2011 Feb 3. Br J Dermatol. 2011. PMID: 21073449 Free PMC article.
Prevalence and treatment patterns of psoriatic arthritis in the UK.
Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H, Gelfand JM. Ogdie A, et al. Among authors: gelfand jm. Rheumatology (Oxford). 2013 Mar;52(3):568-75. doi: 10.1093/rheumatology/kes324. Epub 2012 Dec 7. Rheumatology (Oxford). 2013. PMID: 23221331 Free PMC article.
OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.
Kimball AB, Rothman KJ, Kricorian G, Pariser D, Yamauchi PS, Menter A, Teller CF, Aras G, Accortt NA, Hooper M, Rice KC, Gelfand JM. Kimball AB, et al. Among authors: gelfand jm. J Am Acad Dermatol. 2015 Jan;72(1):115-22. doi: 10.1016/j.jaad.2014.08.050. Epub 2014 Sep 26. J Am Acad Dermatol. 2015. PMID: 25264239 Free PMC article.
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.
Deleuran M, Thaçi D, Beck LA, de Bruin-Weller M, Blauvelt A, Forman S, Bissonnette R, Reich K, Soong W, Hussain I, Foley P, Hide M, Bouaziz JD, Gelfand JM, Sher L, Schuttelaar MLA, Wang C, Chen Z, Akinlade B, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Staudinger H, Graham NMH, Pirozzi G, Ardeleanu M. Deleuran M, et al. Among authors: gelfand jm. J Am Acad Dermatol. 2020 Feb;82(2):377-388. doi: 10.1016/j.jaad.2019.07.074. Epub 2019 Jul 30. J Am Acad Dermatol. 2020. PMID: 31374300 Free article. Clinical Trial.
Srcasm overexpression in psoriasis-insights into pathogenesis.
Pulitzer M, Li W, Hanson M, Singh F, Elenitsas R, Gelfand JM, VanVoorhees A, Seykora JT. Pulitzer M, et al. Among authors: gelfand jm. J Cutan Pathol. 2007 Feb;34(2):160-5. doi: 10.1111/j.1600-0560.2006.00590.x. J Cutan Pathol. 2007. PMID: 17244028
460 results